Psychedelic-augmented psychotherapy for overcoming traumatic dissociation: A review of neuroscientific and phenomenological evidence
Ansgar Rougemont-Bücking, F. Guenot, V. Salamin, Isabelle Gothuey, Catherine Duffour, Julia King-Olivier, Vincent Girard, J. Naudin
European Journal of Trauma & Dissociation June 1, 2024 DOI: 10.1016/j.ejtd.2024.100431 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | Psychedelic-augmented psychotherapy shows promise for treating traumatic dissociation by addressing phobic avoidance, contextualization deficit, and traumatic attachment within the structural dissociation model. |
Abstract
The renewed interest in entactogens and classical psychedelics, particularly in the context of psychotraumatology, has led to the positioning of psychedelic-augmented psychotherapy (PAP) as a highly promising therapeutic approach for traumatic dissociation. In this comprehensive review, findings from empirical studies are combined with observations of patients' phenomenological experience manifesting during the course of PAP. The implications of PAP in relation to the ‘structural dissociation model,’ which assumes the presence of an emotional part (EP) and of an apparently normal part (ANP) of the personality, are highlighted. Three different pathogenic dynamics are considered that typically occur in complexly traumatized patients: phobic avoidance of traumatic memories, contextualization deficit and traumatic attachment. In summary, by re-evaluating phenomenological experiences against the background of neurobiological mechanisms, PAP offers a promising avenue for a deeper understanding and therapeutic resolution of traumatic dissociation, which could fundamentally improve the treatment paradigm for many trauma-related disorders.
Citations in the library
Cited by 9
- Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: a qualitative analysis. Harm Reduction Journal December 9, 2025
- Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: A qualitative analysis Research Square May 13, 2025
- Psychedelics and the thalamocortical system: A scoping review Pharmacology, Biochemistry, and Behavior July 9, 2026
- Variability in outcomes and subjective effects of psychedelic use in psychotic populations: Case-based evidence from naturalistic settings Psychedelics May 14, 2026
- Psychedelic Use and Psychological Healing Among Gender Exploring Clients: Clinicians’ Perspectives Women & Therapy May 12, 2026
and 4 more in the library
Cites 35
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology July 19, 2010
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects Journal of Psychopharmacology November 11, 2014
- 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry May 1, 2018
and 30 more in the library